safingol and HIV Coinfection

safingol has been researched along with HIV Coinfection in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bon, D; Dietz, J; Dultz, G; Ferreiros, N; Grammatikos, G; Gute, P; Herrmann, E; Karakasiliotis, I; Knecht, G; Koch, A; Lutz, T; Mavromara, P; Pfeilschifter, J; Sarrazin, C; Zeuzem, S	1

Other Studies

1 other study(ies) available for safingol and HIV Coinfection

Article	Year
Persistence of HCV in Acutely-Infected Patients Depletes C24-Ceramide and Upregulates Sphingosine and Sphinganine Serum Levels. International journal of molecular sciences, 2016, Jun-13, Volume: 17, Issue:6 Topics: Adult; Angiopoietin-Like Protein 3; Angiopoietin-like Proteins; Angiopoietins; Antiviral Agents; Biomarkers; Ceramides; Coinfection; Female; Genotype; Hepacivirus; Hepatitis C; HIV Infections; Humans; Male; Middle Aged; Sphingosine; Viral Load; Young Adult	2016

Article

Year

Persistence of HCV in Acutely-Infected Patients Depletes C24-Ceramide and Upregulates Sphingosine and Sphinganine Serum Levels.

International journal of molecular sciences, 2016, Jun-13, Volume: 17, Issue:6

Topics: Adult; Angiopoietin-Like Protein 3; Angiopoietin-like Proteins; Angiopoietins; Antiviral Agents; Biomarkers; Ceramides; Coinfection; Female; Genotype; Hepacivirus; Hepatitis C; HIV Infections; Humans; Male; Middle Aged; Sphingosine; Viral Load; Young Adult

2016